Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details)							1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 16, 2024 shares	Oct. 07, 2024	Aug. 26, 2024	Jun. 05, 2024 tradingDay	Sep. 06, 2023	Jun. 30, 2023 USD ($) officer	Nov. 30, 2021 USD ($) stockholder shares	Dec. 31, 2024 USD ($) nonemployee_Director shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2024 USD ($) nonemployee_Director $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2024 USD ($)	Feb. 28, 2022 nonemployee_Director
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Reverse stock split	0.05	0.05
Equity compensation charges										$ 50,467,000	$ 101,198,000
Current liabilities of discontinued operations								$ 9,823,000		$ 9,823,000		$ 21,372,000
Weighted-average grant date fair values of options granted (in usd per share) | $ / shares										$ 4.09	$ 17.40
Intrinsic value of vested options exercised										$ 0	$ 1,200,000
Unrecognized stock-based compensation cost								14,400,000		14,400,000
Total stock-based compensation expense								9,244,000	$ 24,100,000	47,725,000	91,335,000
Discontinued Operations
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense								200,000	2,300,000	2,742,000	9,863,000
Current liabilities of discontinued operations								9,823,000		9,823,000		$ 21,372,000
Lemonaid Health, Inc.
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							4 years
Former officers terminated | officer						1
Lemonaid Health, Inc. | Former Lemonaid Officer
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unrecognized stock-based compensation cost								0		0
Lemonaid Health, Inc. | Former Lemonaid Officer | General and administrative
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation expense								0	3,300,000	$ 0	28,400,000
Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Reverse stock split			0.200
Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Reverse stock split			0.0333
Outstanding stock options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average period over which unrecognized compensation is expected to be recognized										2 years 2 months 12 days
Tax benefit recognized from stock option exercises								0	0	$ 0	0
Outstanding stock options | Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period					3 years
Outstanding stock options | Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period					4 years
Restricted stock units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Granted (in shares) | shares										3,738,075
Weighted average period over which unrecognized compensation is expected to be recognized										2 years 4 months 24 days
Unrecognized stock-based compensation cost								44,200,000		$ 44,200,000
Restricted stock units | Lemonaid Health, Inc. | Former Lemonaid Officer | General and administrative
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total stock-based compensation expense						$ 22,000,000		$ 3,100,000
Class A Common Stock | Lemonaid Health, Inc.
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock granted subject to vest (in shares) | shares							187,352
Common stock granted subject to vest, weighted average grant date fair value							$ 43,900,000
Class A Common Stock | Lemonaid Health, Inc. | Former Lemonaid Officer
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Former stockholders who were granted shares | stockholder							2
A&R Plan | Class A Common Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares authorized (in shares) | shares	10,034,656
Second A And R Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage of shares automatically added annually					5.00%
Non-employee directors, electing to defer settlement of RSUs | nonemployee_Director													2
Non-employee directors, eligible to participate in the program | nonemployee_Director								0		0
Second A And R Plan | Outstanding stock options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based compensation terms of award					Options have a contractual life of up to ten years. The exercise price of a stock option shall not be less than 100% of the estimated fair value of the shares on the date of grant, as determined by the Board of Directors.
Share-based payment award, expiration period					10 years
Exercise price of stock options as a percentage of fair value of shares					100.00%
Number of shares of common stock received for each option exercised					1
Second A And R Plan | Restricted stock units | Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period					1 year
Second A And R Plan | Restricted stock units | Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period					4 years
Annual Incentive Plan | Restricted stock units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Performance period												1 year
Granted (in shares) | shares								607,222
Equity compensation charges								$ (3,400,000)	(2,000,000.0)	$ 3,100,000	3,800,000
Other current liabilities for awards								3,200,000		3,200,000		$ 5,800,000
Current liabilities of discontinued operations								0		0		$ 700,000
Annual Incentive Plan | Restricted stock units | Discontinued Operations
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense								$ (400,000)	$ (500,000)	$ 100,000	$ 500,000
Annual Incentive Plan | Class A Common Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Days preceding date of payment | tradingDay				20
ESPP
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares authorized (in shares) | shares	580,456
ESPP | Employee Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock issued and outstanding, percentage	1.00%
Potential annual increase in shares reserved for future issuance (in shares) | shares	250,000
A And R ESPP
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value (in usd per share) | $ / shares										$ 2.52	$ 8.78
A And R ESPP | Employee Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
ESPP concurrent offering period										12 months
ESPP successive purchase period										6 months
A And R ESPP | Class A Common Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Average exercise price (in usd per share) | $ / shares										$ 5.35	$ 18.70
A And R ESPP | Class A Common Stock | Employee Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of common stock under employee stock purchase plan (in shares) | shares								0	0	61,807	75,472